Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]

Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] was reported 3373 times

Drugs of the Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 REFUSAL OF VACCINATION 2 0.6667
1 ALPHA-2 MACROGLOBULIN INCREASED 1 0.1667
2 DIGESTIVE ENZYME DECREASED 1 0.0714
3 GLUCOSE URINE 9 0.0600
4 GASTROPARESIS POSTOPERATIVE 1 0.0588
5 CREATINE KINASE ABNORMAL 1 0.0417
6 RENAL HYPERTENSION 9 0.0289
7 LIPOPROTEIN (A) INCREASED 9 0.0275
8 BRACHIAL ARTERY ENTRAPMENT SYNDROME 1 0.0263
9 COMPUTERISED TOMOGRAM HEART ABNORMAL 2 0.0244
10 CHRONIC HEPATITIS C 9 0.0228
11 DRUG RECHALLENGE POSITIVE 1 0.0222
12 CORNEAL BLEEDING 2 0.0208
13 BLOOD URIC ACID ABNORMAL 8 0.0196
14 MUSCLE DISCOMFORT 15 0.0191
15 C-TELOPEPTIDE INCREASED 2 0.0189
16 BOWEL OBSTRUCTION SURGERY 1 0.0182
17 CUTANEOUS T-CELL LYMPHOMA RECURRENT 1 0.0159
18 AGITATION POSTOPERATIVE 1 0.0159
19 EXERTIONAL HEADACHE 1 0.0156
20 HYPERTENSIVE URGENCY 8 0.0144
21 GASTRIC PNEUMATOSIS 1 0.0141
22 COUGH VARIANT ASTHMA 1 0.0119
23 BLOOD URIC ACID INCREASED 67 0.0116
24 RETICULOCYTE COUNT INCREASED 9 0.0111
25 NECROTISING MYOSITIS 9 0.0104
26 EYE INFARCTION 1 0.0100
27 LOW DENSITY LIPOPROTEIN ABNORMAL 6 0.0098
28 MUSCLE RUPTURE 34 0.0087
29 LOWER URINARY TRACT SYMPTOMS 3 0.0083
30 MYOSCLEROSIS 3 0.0081
31 MYOGLOBIN BLOOD INCREASED 12 0.0078
32 QUADRIPARESIS 12 0.0072
33 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 9 0.0070
34 GASTRIC VOLVULUS 1 0.0069
35 TENDON DISCOMFORT 5 0.0066
36 BLOOD INSULIN DECREASED 1 0.0065
37 AUTOIMMUNE MYOSITIS 3 0.0064
38 LOW DENSITY LIPOPROTEIN INCREASED 48 0.0062
39 ALCOHOLIC LIVER DISEASE 2 0.0059
40 GIARDIASIS 2 0.0059
41 PSEUDOSTROKE 2 0.0058
42 GINGIVAL OEDEMA 1 0.0057
43 THYMOMA 2 0.0055
44 HIGH DENSITY LIPOPROTEIN DECREASED 18 0.0054
45 GOUT 94 0.0052
46 CHRONIC PIGMENTED PURPURA 1 0.0051
47 CELLULITIS GANGRENOUS 1 0.0051
48 HANGING 1 0.0051
49 TENDON INJURY 18 0.0048
50 ANTIDEPRESSANT DISCONTINUATION SYNDROME 1 0.0048
51 TENDON PAIN 36 0.0047
52 HYPERURICAEMIA 19 0.0046
53 TENDON DISORDER 30 0.0046
54 GOUTY TOPHUS 1 0.0045
55 CORONARY ARTERY ANEURYSM 1 0.0043
56 HIGH DENSITY LIPOPROTEIN ABNORMAL 1 0.0043
57 LOW DENSITY LIPOPROTEIN DECREASED 6 0.0042
58 LIPIDS ABNORMAL 3 0.0041
59 TENDON RUPTURE 50 0.0040
60 DIABETIC VASCULAR DISORDER 1 0.0040
61 RESPIRATORY TRACT IRRITATION 4 0.0038
62 RETROGRADE EJACULATION 3 0.0038
63 ANION GAP ABNORMAL 1 0.0037
64 GLOMERULONEPHRITIS 9 0.0037
65 GASTROENTERITIS ESCHERICHIA COLI 2 0.0037
66 OEDEMATOUS PANCREATITIS 2 0.0036
67 JOINT NOISE 7 0.0036
68 HYPOURICAEMIA 1 0.0034
69 PROTEIN TOTAL INCREASED 9 0.0034
70 DUODENAL OBSTRUCTION 1 0.0033
71 BRONCHOSPASM PARADOXICAL 1 0.0033
72 ALLERGY TO ARTHROPOD BITE 1 0.0031
73 FEAR OF DEATH 7 0.0031
74 COLORECTAL ADENOMA 1 0.0031
75 RESTING TREMOR 2 0.0031
76 ADMINISTRATION SITE SWELLING 1 0.0031
77 HEPATITIS ALCOHOLIC 1 0.0031
78 DISCONTINUED PRODUCT ADMINISTERED 1 0.0030
79 HIGH DENSITY LIPOPROTEIN INCREASED 3 0.0030
80 BLOOD CREATINE PHOSPHOKINASE INCREASED 86 0.0030
81 BLOOD TRIGLYCERIDES DECREASED 1 0.0030
82 LIGAMENT RUPTURE 13 0.0029
83 HYPERALDOSTERONISM 1 0.0029
84 ADMINISTRATION SITE BRUISE 1 0.0029
85 BLOOD OESTROGEN DECREASED 2 0.0028
86 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
87 BURNING SENSATION MUCOSAL 1 0.0028
88 CHRONIC LEFT VENTRICULAR FAILURE 1 0.0028
89 PRODUCT MONITORING ERROR 4 0.0028
90 MYALGIA 468 0.0027
91 DIET NONCOMPLIANCE 1 0.0027
92 RHEUMATOID FACTOR INCREASED 3 0.0027
93 MULTIPLE DRUG THERAPY 2 0.0027
94 CREATINE KINASE INCREASED 2 0.0026
95 GOUTY ARTHRITIS 2 0.0025
96 POST-TRAUMATIC NECK SYNDROME 2 0.0025
97 ENDOMETRIAL DISORDER 1 0.0024
98 PERIORBITAL PAIN 2 0.0024
99 ARTERIAL STENOSIS 2 0.0023
100 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 1 0.0022
101 ALLERGY TO ARTHROPOD STING 1 0.0022
102 EXTRAOCULAR MUSCLE PARESIS 1 0.0022
103 CARDIAC PACEMAKER REPLACEMENT 1 0.0022
104 EATING DISORDER SYMPTOM 1 0.0022
105 JOINT INSTABILITY 3 0.0021
106 STENOSIS 4 0.0021
107 BLOOD ALKALINE PHOSPHATASE DECREASED 2 0.0021
108 PRODUCT AFTER TASTE 2 0.0021
109 BLOOD TRIGLYCERIDES INCREASED 37 0.0021
110 MYOPATHY 18 0.0021
111 GLOMERULAR FILTRATION RATE DECREASED 25 0.0020
112 PROTEIN URINE PRESENT 10 0.0020
113 HYPERCREATININAEMIA 1 0.0020
114 DUODENITIS 6 0.0020
115 TONGUE BITING 4 0.0019
116 NEOPLASM SKIN 3 0.0019
117 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 1 0.0019
118 SINUSITIS BACTERIAL 2 0.0019
119 AUTOSCOPY 1 0.0019
120 INFUSION SITE BRUISING 4 0.0019
121 SKULL FRACTURE 3 0.0018
122 NEPHROTIC SYNDROME 12 0.0017
123 PANCREATITIS NECROTISING 4 0.0017
124 ENANTHEMA 1 0.0017
125 BURN ORAL CAVITY 1 0.0017
126 SERUM FERRITIN DECREASED 3 0.0017
127 LUNG CANCER METASTATIC 5 0.0017
128 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 1 0.0017
129 SINUS PAIN 4 0.0017
130 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
131 FEAR OF DISEASE 3 0.0017
132 CORONAVIRUS INFECTION 11 0.0017
133 MONOPARESIS 3 0.0017
134 MUSCLE FATIGUE 7 0.0017
135 ARTHRITIS REACTIVE 1 0.0016
136 CHALAZION 1 0.0016
137 FASCIITIS 1 0.0015
138 MUSCULOSKELETAL DISCOMFORT 26 0.0015
139 WEIGHT BEARING DIFFICULTY 4 0.0015
140 MUSCLE DISORDER 12 0.0015
141 INTERNATIONAL NORMALISED RATIO ABNORMAL 5 0.0015
142 MAST CELL ACTIVATION SYNDROME 2 0.0014
143 PHOTOPSIA 9 0.0014
144 ANTERIOR CHAMBER CELL 1 0.0014
145 CERVICAL RADICULOPATHY 1 0.0014
146 BLOOD FOLATE DECREASED 1 0.0014
147 GASTRIC MUCOSAL LESION 1 0.0014
148 DRUG-DISEASE INTERACTION 1 0.0014
149 GENERALISED ANXIETY DISORDER 2 0.0014
150 TENDONITIS 21 0.0014
151 INFUSION SITE INDURATION 2 0.0013
152 DRUG EFFECT LESS THAN EXPECTED 20 0.0013
153 BLISTER RUPTURE 1 0.0013
154 CHOLANGITIS ACUTE 1 0.0013
155 DIZZINESS EXERTIONAL 1 0.0013
156 ORAL MUCOSAL ERUPTION 2 0.0013
157 GASTROSTOMY 2 0.0013
158 CORNEAL TRANSPLANT 1 0.0013
159 MEDICAL DEVICE IMPLANTATION 2 0.0013
160 BRONCHIAL CARCINOMA 1 0.0013
161 HEAT EXHAUSTION 1 0.0012
162 CARDIAC FLUTTER 8 0.0012
163 ACNE PUSTULAR 1 0.0012
164 ALLERGIC SINUSITIS 1 0.0012
165 MICTURITION URGENCY 13 0.0011
166 BLOOD ALBUMIN DECREASED 9 0.0011
167 MUSCLE SPASMS 207 0.0011
168 ANAEMIA OF CHRONIC DISEASE 1 0.0011
169 URINE ABNORMALITY 5 0.0011
170 OESOPHAGEAL SPASM 2 0.0011
171 BLOOD CHOLESTEROL ABNORMAL 5 0.0011
172 BLOOD CHOLESTEROL DECREASED 2 0.0011
173 BLOOD UREA ABNORMAL 1 0.0011
174 COLITIS MICROSCOPIC 5 0.0011
175 RENAL PAIN 11 0.0010
176 HYPERVIGILANCE 1 0.0010
177 BILIARY COLIC 3 0.0010
178 ANIMAL SCRATCH 1 0.0010
179 VITAMIN D DEFICIENCY 10 0.0010
180 EYELID RASH 1 0.0010
181 DACTYLITIS 1 0.0010
182 CREPITATIONS 3 0.0010
183 FLUID INTAKE REDUCED 5 0.0010
184 EJACULATION FAILURE 2 0.0010
185 CARDIAC DISCOMFORT 2 0.0010
186 LUPUS-LIKE SYNDROME 9 0.0010
187 LIPIDS INCREASED 2 0.0010
188 BUTTERFLY RASH 1 0.0010
189 TRIGGER FINGER 4 0.0010
190 GASTRIC PH DECREASED 1 0.0010
191 FLANK PAIN 9 0.0010
192 CARPAL TUNNEL DECOMPRESSION 1 0.0009
193 EAR SWELLING 2 0.0009
194 HEPATIC PAIN 4 0.0009
195 ROTATOR CUFF SYNDROME 12 0.0009
196 OVERWEIGHT 5 0.0009
197 HORDEOLUM 4 0.0009
198 GINGIVAL SWELLING 4 0.0009
199 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
200 DEMENTIA WITH LEWY BODIES 1 0.0009
201 ESSENTIAL TREMOR 1 0.0009
202 IDIOPATHIC INTRACRANIAL HYPERTENSION 2 0.0009
203 GASTROINTESTINAL HYPOMOTILITY 2 0.0009
204 HALO VISION 1 0.0009
205 MUSCLE CONTRACTIONS INVOLUNTARY 3 0.0009
206 PROSTATE CANCER STAGE IV 3 0.0008
207 PUSTULE 2 0.0008
208 BRONCHIAL HYPERREACTIVITY 1 0.0008
209 MENISCUS INJURY 5 0.0008
210 SPRUE-LIKE ENTEROPATHY 4 0.0008
211 RETINAL TEAR 2 0.0008
212 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
213 BLADDER DISCOMFORT 1 0.0008
214 CUTANEOUS T-CELL LYMPHOMA 1 0.0008
215 PARANASAL SINUS HYPERSECRETION 3 0.0008
216 ABDOMINAL INFECTION 2 0.0008
217 BLOOD BILIRUBIN ABNORMAL 1 0.0008
218 BILIARY OBSTRUCTION 1 0.0008
219 RESTLESS LEGS SYNDROME 14 0.0008
220 EPIGASTRIC DISCOMFORT 3 0.0008
221 ANGINA PECTORIS 22 0.0008
222 FEELINGS OF WORTHLESSNESS 1 0.0008
223 ARTHRALGIA 315 0.0008
224 INCONTINENCE 8 0.0008
225 MYOCLONUS 9 0.0008
226 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
227 MIGRAINE WITH AURA 2 0.0007
228 MUSCULAR WEAKNESS 83 0.0007
229 GASTROINTESTINAL PAIN 8 0.0007
230 DRUG INTOLERANCE 70 0.0007
231 RHABDOMYOLYSIS 30 0.0007
232 AUTOIMMUNE HEPATITIS 5 0.0007
233 ELECTRIC SHOCK SENSATION 2 0.0007
234 CHROMATURIA 16 0.0007
235 PAIN IN EXTREMITY 208 0.0007
236 CONNECTIVE TISSUE DISORDER 1 0.0007
237 PARALYSIS 10 0.0007
238 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
239 BLOOD CHOLESTEROL INCREASED 32 0.0007
240 CARDIAC FIBRILLATION 1 0.0007
241 URINE ANALYSIS ABNORMAL 2 0.0007
242 EPICONDYLITIS 1 0.0007
243 GINGIVAL HYPERTROPHY 1 0.0007
244 PROSTATITIS 2 0.0007
245 LIPASE INCREASED 5 0.0007
246 GAMMA-GLUTAMYLTRANSFERASE INCREASED 14 0.0006
247 GAIT INABILITY 21 0.0006
248 LOSS OF THERAPEUTIC RESPONSE 2 0.0006
249 CYSTITIS INTERSTITIAL 1 0.0006
250 PRODUCT PREPARATION ISSUE 4 0.0006
251 LIGAMENT SPRAIN 6 0.0006
252 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
253 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
254 ANTIBODY TEST POSITIVE 1 0.0006
255 HEPATIC ENZYME INCREASED 41 0.0006
256 BLOOD UREA INCREASED 10 0.0006
257 PLANTAR FASCIITIS 2 0.0006
258 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
259 CEREBELLAR INFARCTION 1 0.0006
260 DYSLIPIDAEMIA 3 0.0006
261 HEPATOTOXICITY 13 0.0006
262 PANCREATITIS ACUTE 13 0.0006
263 PYELONEPHRITIS 5 0.0006
264 MALABSORPTION 3 0.0006
265 HANGOVER 2 0.0006
266 DEPRESSIVE SYMPTOM 2 0.0006
267 HAEMORRHAGIC DIATHESIS 2 0.0006
268 LIVER FUNCTION TEST INCREASED 12 0.0006
269 ARRHYTHMIA 26 0.0005
270 ESSENTIAL HYPERTENSION 1 0.0005
271 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
272 CALCIPHYLAXIS 1 0.0005
273 AMYLASE INCREASED 2 0.0005
274 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
275 DIVERTICULITIS 15 0.0005
276 NECK PAIN 30 0.0005
277 HYPERTENSIVE HEART DISEASE 1 0.0005
278 OCULAR DISCOMFORT 6 0.0005
279 IMPATIENCE 1 0.0005
280 ARTERIOSCLEROSIS 5 0.0005
281 CHOLECYSTITIS ACUTE 3 0.0005
282 MYOCARDIAL ISCHAEMIA 6 0.0005
283 ARTERIAL DISORDER 1 0.0005
284 GINGIVAL RECESSION 1 0.0005
285 FOOD ALLERGY 4 0.0005
286 HYPERCHOLESTEROLAEMIA 5 0.0005
287 HYPERTRIGLYCERIDAEMIA 3 0.0005
288 PHARYNGEAL SWELLING 5 0.0005
289 PANCREATITIS 27 0.0005
290 HYPOGEUSIA 1 0.0005
291 URINARY RETENTION 17 0.0005
292 ASPARTATE AMINOTRANSFERASE INCREASED 27 0.0005
293 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
294 THIRST 9 0.0005
295 CHOLECYSTITIS 6 0.0005
296 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
297 STENT PLACEMENT 4 0.0005
298 FUNGAL SKIN INFECTION 2 0.0005
299 MYASTHENIA GRAVIS 4 0.0005
300 EYELID PAIN 1 0.0005
301 IMMUNE-MEDIATED HEPATITIS 1 0.0005
302 CHANGE OF BOWEL HABIT 1 0.0005
303 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
304 TENDERNESS 5 0.0005
305 PRODUCT ODOUR ABNORMAL 5 0.0005
306 INFUSION SITE SWELLING 3 0.0005
307 ONYCHOMADESIS 2 0.0005
308 PROTEINURIA 9 0.0005
309 ABDOMINAL PAIN UPPER 97 0.0005
310 PULMONARY FIBROSIS 9 0.0005
311 SHOULDER OPERATION 2 0.0005
312 PRODUCT DISPENSING ISSUE 2 0.0005
313 TEARFULNESS 2 0.0005
314 EXOPHTHALMOS 1 0.0005
315 HEPATITIS ACUTE 3 0.0005
316 DIVERTICULUM INTESTINAL 2 0.0005
317 EOSINOPHILIA 8 0.0005
318 BACK PAIN 106 0.0005
319 ACCIDENT AT WORK 1 0.0005
320 VULVOVAGINAL DISCOMFORT 2 0.0005
321 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
322 BLOOD CREATINE INCREASED 2 0.0005
323 FAECES PALE 1 0.0004
324 BRAIN FOG 7 0.0004
325 CORNEAL OEDEMA 1 0.0004
326 MYOSITIS 4 0.0004
327 GASTRIC POLYPS 1 0.0004
328 ABNORMAL LOSS OF WEIGHT 3 0.0004
329 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
330 HAEMATOCRIT INCREASED 1 0.0004
331 SYNOVIAL CYST 2 0.0004
332 CHOLELITHIASIS 14 0.0004
333 PHOTOSENSITIVITY REACTION 7 0.0004
334 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
335 COAGULOPATHY 7 0.0004
336 RHINORRHOEA 27 0.0004
337 NEURALGIA 10 0.0004
338 BONE PAIN 24 0.0004
339 ARTHRITIS 32 0.0004
340 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
341 ABDOMINAL TENDERNESS 2 0.0004
342 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
343 VEIN DISORDER 2 0.0004
344 ABDOMINAL DISCOMFORT 67 0.0004
345 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
346 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
347 HAEMORRHAGE URINARY TRACT 1 0.0004
348 ANGLE CLOSURE GLAUCOMA 1 0.0004
349 FLATULENCE 22 0.0004
350 MUSCULOSKELETAL CHEST PAIN 6 0.0004
351 APHTHOUS ULCER 3 0.0004
352 DYSPEPSIA 38 0.0004
353 POLLAKIURIA 16 0.0004
354 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
355 SENSITIVITY TO WEATHER CHANGE 2 0.0004
356 GASTROINTESTINAL DISORDER 34 0.0004
357 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
358 POLYARTHRITIS 2 0.0004
359 SERUM FERRITIN INCREASED 2 0.0004
360 ADVERSE REACTION 5 0.0004
361 GINGIVAL PAIN 3 0.0004
362 ABDOMINAL MASS 1 0.0004
363 JOINT SWELLING 45 0.0004
364 QUALITY OF LIFE DECREASED 5 0.0004
365 NIGHT SWEATS 12 0.0004
366 EAR CONGESTION 1 0.0004
367 FAECES DISCOLOURED 8 0.0004
368 RENAL IMPAIRMENT 31 0.0004
369 ABDOMINAL RIGIDITY 1 0.0004
370 PRODUCT DISPENSING ERROR 8 0.0004
371 IMPAIRED GASTRIC EMPTYING 5 0.0004
372 ABNORMAL FAECES 3 0.0004
373 DRUG LEVEL INCREASED 6 0.0004
374 MUSCLE INJURY 3 0.0004
375 MOBILITY DECREASED 26 0.0004
376 HYPERTENSIVE CRISIS 4 0.0004
377 PALPITATIONS 42 0.0004
378 PRODUCT LEAKAGE 2 0.0004
379 BLOOD TEST ABNORMAL 5 0.0004
380 INFUSION SITE ERYTHEMA 3 0.0004
381 PERIORBITAL SWELLING 2 0.0004
382 BLOOD CREATININE INCREASED 23 0.0004
383 CHOLECYSTECTOMY 4 0.0003
384 HEART VALVE INCOMPETENCE 1 0.0003
385 CORONARY ARTERY BYPASS 2 0.0003
386 SKIN ATROPHY 2 0.0003
387 NIGHTMARE 12 0.0003
388 MUSCLE STRAIN 3 0.0003
389 MOUTH SWELLING 2 0.0003
390 SKIN SWELLING 3 0.0003
391 RESPIRATORY TRACT INFECTION 9 0.0003
392 DYSPNOEA AT REST 1 0.0003
393 GROIN PAIN 3 0.0003
394 SPINAL OSTEOARTHRITIS 3 0.0003
395 SPINAL PAIN 4 0.0003
396 HEAD DISCOMFORT 6 0.0003
397 PERIPHERAL SWELLING 52 0.0003
398 DIZZINESS 168 0.0003
399 EYE PAIN 19 0.0003
400 DISEASE RECURRENCE 16 0.0003
401 CARDIAC PACEMAKER INSERTION 2 0.0003
402 DERMATITIS 7 0.0003
403 BLOOD PRESSURE INCREASED 51 0.0003
404 ANAL INCONTINENCE 3 0.0003
405 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
406 RASH PRURITIC 18 0.0003
407 OROPHARYNGEAL DISCOMFORT 3 0.0003
408 CEREBROVASCULAR DISORDER 1 0.0003
409 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
410 INJECTION SITE VESICLES 2 0.0003
411 CRANIOCEREBRAL INJURY 1 0.0003
412 BURSITIS 4 0.0003
413 INGUINAL HERNIA 2 0.0003
414 DERMATITIS ACNEIFORM 2 0.0003
415 DYSCHEZIA 1 0.0003
416 DYSAESTHESIA 1 0.0003
417 FIBROSIS 1 0.0003
418 PRODUCT DISTRIBUTION ISSUE 3 0.0003
419 LIMB DISCOMFORT 10 0.0003
420 INFUSION SITE EXTRAVASATION 2 0.0003
421 SWOLLEN TONGUE 10 0.0003
422 BLOOD CREATININE DECREASED 1 0.0003
423 BLEPHAROSPASM 2 0.0003
424 FOREIGN BODY IN THROAT 1 0.0003
425 PRODUCT USE COMPLAINT 5 0.0003
426 BLADDER PAIN 1 0.0003
427 TRANSAMINASES INCREASED 7 0.0003
428 BILE DUCT STONE 1 0.0003
429 LETHARGY 18 0.0003
430 CHEST DISCOMFORT 32 0.0003
431 SNEEZING 7 0.0003
432 ADVERSE DRUG REACTION 28 0.0003
433 HEART RATE IRREGULAR 7 0.0003
434 DIZZINESS POSTURAL 3 0.0003
435 DYSSTASIA 9 0.0003
436 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2 0.0003
437 ORAL HERPES 6 0.0003
438 BREAST ENLARGEMENT 1 0.0003
439 URINARY INCONTINENCE 9 0.0003
440 BLOOD PRESSURE ABNORMAL 6 0.0003
441 CEREBRAL HAEMATOMA 1 0.0003
442 PRODUCT PHYSICAL ISSUE 6 0.0003
443 SUICIDAL IDEATION 27 0.0003
444 EYE MOVEMENT DISORDER 2 0.0003
445 PERIPHERAL COLDNESS 4 0.0003
446 AORTIC STENOSIS 1 0.0003
447 HUNGER 4 0.0003
448 DRUG-INDUCED LIVER INJURY 9 0.0003
449 CARPAL TUNNEL SYNDROME 4 0.0003
450 SKIN REACTION 4 0.0003
451 SEASONAL ALLERGY 4 0.0003
452 FACIAL PARESIS 1 0.0003
453 PRODUCT SUPPLY ISSUE 2 0.0003
454 ABDOMINAL PAIN 65 0.0003
455 CAROTID ARTERY OCCLUSION 1 0.0003
456 CUTANEOUS VASCULITIS 1 0.0003
457 INTENTIONAL UNDERDOSE 2 0.0003
458 ASTHMATIC CRISIS 1 0.0003
459 BLOOD PHOSPHORUS DECREASED 1 0.0003
460 TOOTH FRACTURE 3 0.0003
461 SKIN DISORDER 9 0.0003
462 FEELING DRUNK 2 0.0003
463 HYPERACUSIS 1 0.0003
464 KETOACIDOSIS 2 0.0003
465 GASTRITIS 7 0.0003
466 AUTOIMMUNE THYROIDITIS 1 0.0003
467 IMPAIRED DRIVING ABILITY 3 0.0003
468 FACE INJURY 1 0.0003
469 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
470 GASTRIC INFECTION 1 0.0003
471 GINGIVAL DISORDER 1 0.0003
472 ATRIOVENTRICULAR BLOCK 2 0.0003
473 FAECES HARD 1 0.0003
474 BURNING SENSATION 18 0.0003
475 CHOKING 5 0.0003
476 INFLUENZA LIKE ILLNESS 21 0.0003
477 HEADACHE 159 0.0003
478 OCULAR HYPERAEMIA 12 0.0003
479 MENTAL DISORDER 11 0.0003
480 FURUNCLE 2 0.0003
481 POLYNEUROPATHY 3 0.0003
482 MOVEMENT DISORDER 8 0.0002
483 CYSTITIS HAEMORRHAGIC 1 0.0002
484 RHINITIS 2 0.0002
485 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
486 MUSCLE TIGHTNESS 4 0.0002
487 BLOOD POTASSIUM INCREASED 4 0.0002
488 POST PROCEDURAL INFECTION 2 0.0002
489 SMALL INTESTINAL OBSTRUCTION 3 0.0002
490 SPINAL OPERATION 3 0.0002
491 HYPERAESTHESIA 2 0.0002
492 ILLNESS 25 0.0002
493 SLEEP DISORDER 17 0.0002
494 GAIT DISTURBANCE 46 0.0002
495 LIP SWELLING 8 0.0002
496 EOSINOPHIL COUNT INCREASED 2 0.0002
497 NEPHROLITHIASIS 11 0.0002
498 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
499 MUSCLE ATROPHY 3 0.0002
500 VITAMIN D DECREASED 2 0.0002
501 DIARRHOEA 151 0.0002
502 CARDIAC OPERATION 2 0.0002
503 POOR QUALITY SLEEP 5 0.0002
504 HAEMATOMA 6 0.0002
505 HEPATIC LESION 1 0.0002
506 CORONARY ARTERY DISEASE 7 0.0002
507 CHAPPED LIPS 1 0.0002
508 PLATELET COUNT INCREASED 3 0.0002
509 ABDOMINAL DISTENSION 24 0.0002
510 PRODUCT PRESCRIBING ISSUE 5 0.0002
511 IMMOBILE 1 0.0002
512 URINE OUTPUT DECREASED 2 0.0002
513 ALANINE AMINOTRANSFERASE INCREASED 14 0.0002
514 DYSPHEMIA 1 0.0002
515 RASH 98 0.0002
516 GASTROINTESTINAL INFECTION 2 0.0002
517 NAUSEA 176 0.0002
518 SINUS CONGESTION 3 0.0002
519 PRODUCT TASTE ABNORMAL 3 0.0002
520 FATIGUE 172 0.0002
521 LIP DRY 2 0.0002
522 MOOD ALTERED 6 0.0002
523 C-REACTIVE PROTEIN INCREASED 8 0.0002
524 CORONARY ARTERY OCCLUSION 3 0.0002
525 INCREASED TENDENCY TO BRUISE 2 0.0002
526 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
527 EYE OPERATION 1 0.0002
528 UROSEPSIS 2 0.0002
529 NERVE COMPRESSION 2 0.0002
530 ORAL DISCOMFORT 3 0.0002
531 ATRIAL FIBRILLATION 21 0.0002
532 SWELLING FACE 14 0.0002
533 APHONIA 3 0.0002
534 HEPATIC STEATOSIS 4 0.0002
535 ERYTHEMA MULTIFORME 2 0.0002
536 DRUG INTERACTION 34 0.0002
537 THERAPY CESSATION 11 0.0002
538 MIDDLE INSOMNIA 4 0.0002
539 DISCOMFORT 13 0.0002
540 PHOTOPHOBIA 4 0.0002
541 PAIN IN JAW 6 0.0002
542 BLOOD URINE PRESENT 4 0.0002
543 IMPAIRED QUALITY OF LIFE 3 0.0002
544 FEELING ABNORMAL 50 0.0002
545 BLOOD PRESSURE FLUCTUATION 5 0.0002
546 HUMERUS FRACTURE 1 0.0002
547 SKIN FISSURES 4 0.0002
548 VISION BLURRED 28 0.0002
549 HEPATOMEGALY 2 0.0002
550 ACUTE MYOCARDIAL INFARCTION 6 0.0002
551 VITREOUS FLOATERS 2 0.0002
552 PARAESTHESIA 32 0.0002
553 BODY TEMPERATURE DECREASED 2 0.0002
554 ACUTE KIDNEY INJURY 31 0.0002
555 HOSPICE CARE 2 0.0002
556 SINUS DISORDER 4 0.0002
557 PRESCRIBED UNDERDOSE 4 0.0002
558 HYPOTONIA 2 0.0002
559 HYPERKALAEMIA 7 0.0002
560 TOXIC SKIN ERUPTION 2 0.0002
561 DRY THROAT 2 0.0002
562 INSURANCE ISSUE 3 0.0002
563 TINNITUS 9 0.0002
564 INJECTION SITE RASH 6 0.0002
565 HEPATITIS 5 0.0002
566 NEUTROPHIL COUNT INCREASED 2 0.0002
567 FEMORAL NECK FRACTURE 1 0.0002
568 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
569 SKIN ULCER 5 0.0002
570 POOR VENOUS ACCESS 2 0.0002
571 VENTRICULAR EXTRASYSTOLES 2 0.0002
572 JOINT STIFFNESS 5 0.0002
573 BLOOD LACTIC ACID INCREASED 1 0.0002
574 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
575 MALAISE 83 0.0002
576 SUDDEN DEATH 2 0.0002
577 SCIATICA 3 0.0002
578 JOINT INJURY 4 0.0002
579 CONTUSION 18 0.0002
580 WHEEZING 11 0.0002
581 GINGIVITIS 1 0.0002
582 DECREASED ACTIVITY 2 0.0002
583 THROAT TIGHTNESS 5 0.0002
584 BACK DISORDER 3 0.0002
585 SKIN LACERATION 2 0.0002
586 CONSTIPATION 40 0.0002
587 MUSCULOSKELETAL STIFFNESS 16 0.0002
588 BLOOD GLUCOSE FLUCTUATION 2 0.0002
589 ASTHENOPIA 1 0.0002
590 INJECTION SITE NODULE 2 0.0002
591 DEAFNESS UNILATERAL 1 0.0002
592 ABNORMAL DREAMS 5 0.0002
593 FOOT DEFORMITY 2 0.0002
594 STEVENS-JOHNSON SYNDROME 4 0.0002
595 RASH MACULO-PAPULAR 4 0.0002
596 ANGER 6 0.0002
597 EYE INFECTION 2 0.0002
598 HEMIPARESIS 3 0.0002
599 PRODUCT DOSE OMISSION ISSUE 52 0.0002
600 ASTHENIA 66 0.0002
601 DYSPNOEA 99 0.0002
602 PRURITUS 67 0.0002
603 PAIN 107 0.0002
604 EXERCISE TOLERANCE DECREASED 1 0.0002
605 MUSCLE TWITCHING 4 0.0002
606 POST PROCEDURAL HAEMORRHAGE 2 0.0002
607 HYPERCHLORHYDRIA 1 0.0002
608 VISUAL IMPAIRMENT 21 0.0002
609 ENERGY INCREASED 1 0.0002
610 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
611 INSOMNIA 45 0.0002
612 NEUROPATHY PERIPHERAL 16 0.0002
613 PRODUCT PRESCRIBING ERROR 4 0.0002
614 PRODUCTIVE COUGH 8 0.0002
615 MACULAR DEGENERATION 2 0.0002
616 HYPERLIPIDAEMIA 2 0.0002
617 SYNOVITIS 3 0.0002
618 ADRENAL INSUFFICIENCY 2 0.0002
619 NOCTURIA 2 0.0002
620 HYPERGLYCAEMIA 6 0.0002
621 VERTIGO 10 0.0002
622 CYTOPENIA 2 0.0002
623 OROPHARYNGEAL PAIN 15 0.0002
624 GENERALISED OEDEMA 2 0.0002
625 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 29 0.0002
626 EPISTAXIS 12 0.0002
627 INJECTION SITE DISCOLOURATION 2 0.0002
628 SECRETION DISCHARGE 2 0.0002
629 DYSPNOEA EXERTIONAL 6 0.0002
630 HOT FLUSH 12 0.0002
631 BLOOD SODIUM DECREASED 3 0.0002
632 HYPOCALCAEMIA 3 0.0002
633 GASTRIC ULCER 3 0.0002
634 MIGRAINE 15 0.0002
635 COUGH 44 0.0002
636 FOREIGN BODY SENSATION IN EYES 1 0.0002
637 INFUSION SITE PAIN 2 0.0002
638 INFLAMMATION 8 0.0002
639 DIPLOPIA 4 0.0002
640 HERPES SIMPLEX 1 0.0002
641 NASAL CONGESTION 9 0.0002
642 BRADYPHRENIA 1 0.0002
643 SKIN DISCOLOURATION 7 0.0002
644 IMPAIRED HEALING 5 0.0002
645 BEDRIDDEN 2 0.0002
646 TOOTH INFECTION 2 0.0002
647 DISABILITY 3 0.0002
648 CATARACT 9 0.0002
649 DEVICE DIFFICULT TO USE 10 0.0002
650 DEPRESSION 34 0.0001
651 CHOLECYSTITIS CHRONIC 1 0.0001
652 URTICARIA 25 0.0001
653 SOMNOLENCE 30 0.0001
654 BRONCHITIS 11 0.0001
655 PRODUCT ADMINISTRATION ERROR 3 0.0001
656 BRONCHIECTASIS 1 0.0001
657 COLITIS ISCHAEMIC 1 0.0001
658 TASTE DISORDER 3 0.0001
659 LIMB INJURY 4 0.0001
660 PRODUCT PREPARATION ERROR 3 0.0001
661 ECCHYMOSIS 1 0.0001
662 CHRONIC KIDNEY DISEASE 11 0.0001
663 HAIR GROWTH ABNORMAL 1 0.0001
664 MEDICATION ERROR 8 0.0001
665 EXTRASYSTOLES 1 0.0001
666 DEMENTIA 4 0.0001
667 DEFAECATION URGENCY 1 0.0001
668 KNEE ARTHROPLASTY 3 0.0001
669 CONFUSIONAL STATE 23 0.0001
670 DEVICE OCCLUSION 2 0.0001
671 DUODENAL ULCER 1 0.0001
672 CHEST PAIN 26 0.0001
673 IMPAIRED WORK ABILITY 3 0.0001
674 FEAR OF INJECTION 1 0.0001
675 SWELLING 13 0.0001
676 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 28 0.0001
677 DERMATITIS BULLOUS 1 0.0001
678 HYPERTHYROIDISM 2 0.0001
679 FAECES SOFT 1 0.0001
680 PRODUCT USE IN UNAPPROVED INDICATION 34 0.0001
681 APATHY 2 0.0001
682 GASTROENTERITIS 2 0.0001
683 DYSPHONIA 8 0.0001
684 SINUSITIS 14 0.0001
685 APPLICATION SITE PAIN 3 0.0001
686 BLINDNESS TRANSIENT 1 0.0001
687 LABORATORY TEST ABNORMAL 4 0.0001
688 EYE SWELLING 5 0.0001
689 PULMONARY MASS 2 0.0001
690 HEPATIC FUNCTION ABNORMAL 5 0.0001
691 THROAT IRRITATION 6 0.0001
692 MUSCULOSKELETAL PAIN 7 0.0001
693 HYDRONEPHROSIS 1 0.0001
694 GENERAL SYMPTOM 1 0.0001
695 HYPOAESTHESIA ORAL 2 0.0001
696 INTESTINAL OBSTRUCTION 5 0.0001
697 LACRIMATION INCREASED 4 0.0001
698 AORTIC ANEURYSM 1 0.0001
699 OEDEMA PERIPHERAL 16 0.0001
700 BOWEL MOVEMENT IRREGULARITY 1 0.0001
701 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
702 FEELING HOT 8 0.0001
703 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
704 THYROID DISORDER 2 0.0001
705 WEIGHT DECREASED 36 0.0001
706 RENAL DISORDER 6 0.0001
707 TREATMENT NONCOMPLIANCE 7 0.0001
708 DRUG DOSE OMISSION BY DEVICE 10 0.0001
709 GASTROINTESTINAL INFLAMMATION 1 0.0001
710 BLOOD GLUCOSE INCREASED 24 0.0001
711 BALANCE DISORDER 11 0.0001
712 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
713 AFFECTIVE DISORDER 1 0.0001
714 HYPOAESTHESIA 19 0.0001
715 THERAPY INTERRUPTED 9 0.0001
716 OBESITY 2 0.0001
717 RASH ERYTHEMATOUS 6 0.0001
718 ATRIAL FLUTTER 1 0.0001
719 BLOOD DISORDER 1 0.0001
720 SENSORY DISTURBANCE 2 0.0001
721 URINARY TRACT INFECTION 21 0.0001
722 DYSKINESIA 5 0.0001
723 INJECTION SITE URTICARIA 3 0.0001
724 METASTASES TO BONE 2 0.0001
725 HICCUPS 1 0.0001
726 ERYTHEMA 25 0.0001
727 EYE IRRITATION 7 0.0001
728 GENERAL PHYSICAL HEALTH DETERIORATION 14 0.0001
729 ACUTE CORONARY SYNDROME 1 0.0001
730 RENAL FAILURE 16 0.0001
731 NASOPHARYNGITIS 22 0.0001
732 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
733 SKIN EXFOLIATION 10 0.0001
734 DIABETES MELLITUS 9 0.0001
735 HYPERTENSION 25 0.0001
736 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
737 FACIAL PARALYSIS 1 0.0001
738 HYPERHIDROSIS 15 0.0001
739 IRRITABILITY 7 0.0001
740 BLOOD MAGNESIUM DECREASED 1 0.0001
741 RASH MACULAR 4 0.0001
742 BLOOD CALCIUM INCREASED 1 0.0001
743 DEPRESSED MOOD 6 0.0001
744 COLD SWEAT 2 0.0001
745 LYMPHOCYTE COUNT DECREASED 2 0.0001
746 HYPERSENSITIVITY 21 0.0001
747 DRUG ERUPTION 2 0.0001
748 TACHYCARDIA 10 0.0001
749 GALLBLADDER DISORDER 2 0.0001
750 FACIAL PAIN 1 0.0001
751 HAEMOLYTIC ANAEMIA 1 0.0001
752 THERAPY NON-RESPONDER 5 0.0001
753 HEAVY MENSTRUAL BLEEDING 1 0.0001
754 DRY MOUTH 9 0.0001
755 TOOTHACHE 2 0.0001
756 PELVIC PAIN 2 0.0001
757 SYNCOPE 11 0.0001
758 LOSS OF CONSCIOUSNESS 14 0.0001
759 MEMORY IMPAIRMENT 15 0.0001
760 BRAIN NEOPLASM 1 0.0001
761 RESPIRATORY DISTRESS 3 0.0001
762 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
763 INJECTION SITE MASS 4 0.0001
764 AMNESIA 7 0.0001
765 HAEMOPTYSIS 3 0.0001
766 THINKING ABNORMAL 2 0.0001
767 COGNITIVE DISORDER 5 0.0001
768 FOOT FRACTURE 2 0.0001
769 BLOOD PRESSURE DECREASED 7 0.0001
770 ANAEMIA 20 0.0001
771 INCREASED APPETITE 2 0.0001
772 HYPERSOMNIA 3 0.0001
773 POST PROCEDURAL COMPLICATION 2 0.0001
774 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
775 AFFECT LABILITY 1 0.0001
776 GLAUCOMA 2 0.0001
777 ERUCTATION 2 0.0001
778 LIVER FUNCTION TEST ABNORMAL 3 0.0001
779 AUTOIMMUNE DISORDER 1 0.0001
780 HAEMORRHOIDS 2 0.0001
781 SURGERY 6 0.0001
782 COELIAC DISEASE 1 0.0001
783 DISORIENTATION 4 0.0001
784 HEART RATE INCREASED 10 0.0001
785 DRY EYE 5 0.0001
786 FALL 33 0.0001
787 FEEDING DISORDER 2 0.0001
788 EPILEPSY 3 0.0001
789 BODY TEMPERATURE INCREASED 2 0.0001
790 EUPHORIC MOOD 1 0.0001
791 EAR DISCOMFORT 1 0.0001
792 ASTHMA 11 0.0001
793 INJECTION SITE ERYTHEMA 12 0.0001
794 ECZEMA 5 0.0001
795 SPEECH DISORDER 5 0.0001
796 DYSPHAGIA 9 0.0001
797 HEAD INJURY 3 0.0001
798 OSTEOARTHRITIS 4 0.0001
799 DYSGEUSIA 7 0.0001
800 CYSTITIS 3 0.0001
801 RETCHING 2 0.0001
802 BREAST PAIN 1 0.0001
803 BODY HEIGHT DECREASED 1 0.0001
804 DISTURBANCE IN ATTENTION 5 0.0001
805 BACK INJURY 1 0.0001
806 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
807 HAEMATOCHEZIA 5 0.0001
808 ANGIOEDEMA 4 0.0001
809 DENTAL CARIES 1 0.0001
810 EXPIRED PRODUCT ADMINISTERED 3 0.0001
811 FUNGAL INFECTION 3 0.0001
812 ARTHROPATHY 5 0.0001
813 INJECTION SITE PRURITUS 6 0.0001
814 PULMONARY OEDEMA 4 0.0001
815 WEIGHT INCREASED 20 0.0001
816 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
817 INJECTION SITE BRUISING 7 0.0001
818 DERMATITIS CONTACT 1 0.0001
819 HAEMOGLOBIN DECREASED 9 0.0001
820 SHOCK 2 0.0001
821 GASTRIC HAEMORRHAGE 1 0.0001
822 ELECTROLYTE IMBALANCE 1 0.0001
823 HEART RATE DECREASED 3 0.0001
824 HYPOXIA 3 0.0001
825 OFF LABEL USE 74 0.0001
826 TREMOR 14 0.0001
827 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
828 BLOOD IRON DECREASED 1 0.0001
829 CEREBRAL HAEMORRHAGE 3 0.0001
830 VOMITING 39 0.0001
831 HEPATITIS C 1 0.0001
832 MENTAL IMPAIRMENT 2 0.0001
833 HYPOGLYCAEMIA 4 0.0001
834 PANIC ATTACK 3 0.0001
835 FIBROMYALGIA 2 0.0001
836 PRESYNCOPE 2 0.0001
837 DYSURIA 3 0.0001
838 INFLUENZA 9 0.0001
839 ILEUS 1 0.0001
840 AGEUSIA 2 0.0001
841 LEUKOPENIA 4 0.0001
842 COVID-19 14 0.0001
843 DERMATITIS ALLERGIC 1 0.0001
844 UNEVALUABLE EVENT 6 0.0001
845 CARDIOVASCULAR DISORDER 2 0.0001
846 FLUID RETENTION 4 0.0001
847 HEPATIC CYTOLYSIS 1 0.0001
848 DEVICE DEPLOYMENT ISSUE 1 0.0001
849 INJECTION SITE PAIN 24 0.0001
850 ERECTILE DYSFUNCTION 2 0.0001
851 HIATUS HERNIA 1 0.0001
852 EXPOSURE VIA SKIN CONTACT 2 0.0001
853 DEEP VEIN THROMBOSIS 5 0.0001
854 CEREBROVASCULAR ACCIDENT 13 0.0001
855 IMMUNE SYSTEM DISORDER 1 0.0001
856 EAR INFECTION 2 0.0001
857 DEHYDRATION 10 0.0001
858 EYE HAEMORRHAGE 1 0.0001
859 HYPOTENSION 15 0.0001
860 PRODUCT USE ISSUE 14 0.0001
861 PSORIATIC ARTHROPATHY 3 0.0001
862 PALLOR 2 0.0001
863 GINGIVAL BLEEDING 1 0.0001
864 ANAPHYLACTIC REACTION 4 0.0001
865 MENTAL STATUS CHANGES 2 0.0001
866 FEELING COLD 2 0.0001
867 ROAD TRAFFIC ACCIDENT 3 0.0001
868 COORDINATION ABNORMAL 1 0.0001
869 BLINDNESS UNILATERAL 1 0.0001
870 HEPATOCELLULAR INJURY 1 0.0001
871 RED BLOOD CELL COUNT DECREASED 2 0.0001
872 INFECTION 10 0.0001
873 PRODUCT STORAGE ERROR 6 0.0001
874 DRUG INEFFECTIVE 90 0.0001
875 COLON CANCER 1 0.0001
876 RESPIRATORY DISORDER 2 0.0001
877 PYREXIA 23 0.0001
878 ALOPECIA 13 0.0001
879 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
880 ILL-DEFINED DISORDER 4 0.0001
881 CONDITION AGGRAVATED 20 0.0001
882 HIP ARTHROPLASTY 1 0.0001
883 INJECTION SITE SWELLING 5 0.0001
884 NERVOUS SYSTEM DISORDER 2 0.0001
885 MOOD SWINGS 2 0.0001
886 HYPOTHYROIDISM 2 0.0001
887 LACTIC ACIDOSIS 2 0.0001
888 PSORIASIS 8 0.0001
889 VIRAL INFECTION 2 0.0001
890 CHILLS 7 0.0001
891 EYE PRURITUS 2 0.0001
892 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
893 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
894 DISEASE PROGRESSION 7 0.0001
895 CIRCULATORY COLLAPSE 1 0.0001
896 HAEMATURIA 2 0.0001
897 DEVICE DEFECTIVE 1 0.0001
898 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
899 BRADYCARDIA 3 0.0001
900 ANXIETY 16 0.0001
901 OEDEMA 3 0.0001
902 CRYING 2 0.0001
903 RESTLESSNESS 2 0.0001
904 ADVERSE EVENT 5 0.0001
905 BLOOD GLUCOSE ABNORMAL 1 0.0001
906 PANCYTOPENIA 3 0.0001
907 BACTERIAL INFECTION 1 0.0001
908 TOXICITY TO VARIOUS AGENTS 9 0.0001
909 DYSARTHRIA 2 0.0001
910 FRACTURE 1 0.0001
911 COLITIS 2 0.0001
912 CHOLESTASIS 1 0.0001
913 SEIZURE 6 0.0001
914 HERNIA 1 0.0001
915 DYSTONIA 1 0.0001
916 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
917 HAEMATOCRIT DECREASED 1 0.0001
918 CARDIAC FAILURE 4 0.0000
919 THERAPEUTIC RESPONSE DECREASED 3 0.0000
920 FLUSHING 5 0.0000
921 BLINDNESS 2 0.0000
922 OSTEOPOROSIS 2 0.0000
923 HAEMORRHAGE 5 0.0000
924 EATING DISORDER 1 0.0000
925 HYPOACUSIS 2 0.0000
926 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
927 INFUSION RELATED REACTION 3 0.0000
928 GLOSSODYNIA 1 0.0000
929 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
930 HYPOKALAEMIA 2 0.0000
931 DECREASED APPETITE 10 0.0000
932 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
933 INJURY 3 0.0000
934 PULMONARY EMBOLISM 4 0.0000
935 SKIN BURNING SENSATION 3 0.0000
936 ENCEPHALOPATHY 1 0.0000
937 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
938 HALLUCINATION 3 0.0000
939 CELLULITIS 2 0.0000
940 ABDOMINAL PAIN LOWER 1 0.0000
941 HAEMATEMESIS 1 0.0000
942 HYPOPHAGIA 1 0.0000
943 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
944 APPLICATION SITE ERYTHEMA 1 0.0000
945 DRY SKIN 5 0.0000
946 FEAR 1 0.0000
947 FREQUENT BOWEL MOVEMENTS 1 0.0000
948 BLOOD BILIRUBIN INCREASED 1 0.0000
949 CARDIAC ARREST 3 0.0000
950 BLISTER 2 0.0000
951 RHEUMATOID ARTHRITIS 4 0.0000
952 HERPES ZOSTER 2 0.0000
953 INTENTIONAL PRODUCT MISUSE 3 0.0000
954 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
955 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
956 ASCITES 1 0.0000
957 DEVICE ISSUE 3 0.0000
958 BLOOD POTASSIUM DECREASED 1 0.0000
959 HEPATIC FAILURE 1 0.0000
960 APHASIA 1 0.0000
961 PLEURAL EFFUSION 2 0.0000
962 GYNAECOMASTIA 1 0.0000
963 EYE DISORDER 1 0.0000
964 NEUTROPENIA 4 0.0000
965 GASTRIC DISORDER 1 0.0000
966 DEVICE USE ERROR 1 0.0000
967 MYOCARDIAL INFARCTION 5 0.0000
968 PLATELET COUNT DECREASED 3 0.0000
969 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
970 ACCIDENTAL OVERDOSE 1 0.0000
971 AGITATION 2 0.0000
972 HOSPITALISATION 4 0.0000
973 INJECTION SITE HAEMORRHAGE 2 0.0000
974 PNEUMONIA 8 0.0000
975 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
976 DEATH 20 0.0000
977 DEVICE LEAKAGE 1 0.0000
978 COLITIS ULCERATIVE 1 0.0000
979 BREAST CANCER 2 0.0000
980 CARDIAC DISORDER 2 0.0000
981 BLOOD GLUCOSE DECREASED 1 0.0000
982 AGGRESSION 1 0.0000
983 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
984 DERMATITIS ATOPIC 1 0.0000
985 NO ADVERSE EVENT 3 0.0000
986 EMOTIONAL DISTRESS 2 0.0000
987 DEVICE MALFUNCTION 1 0.0000
988 ACNE 1 0.0000
989 INCORRECT DOSE ADMINISTERED 3 0.0000
990 CARDIAC FAILURE CONGESTIVE 1 0.0000
991 DRUG WITHDRAWAL SYNDROME 1 0.0000
992 OVERDOSE 2 0.0000